Given the unique products OSX have in their portfolio, it is an attractive proposition for a takeover. However, since the company has not been able to make sizeable/ noteworthy inroads into the medical market, a potential buyer may not bid aggressively. Even if OSX gets an offer 50% higher than the current market price, it would be around 48cents per share. At that price, unfortunately most retail investors will not still break even.
At current levels, I am undecided if I want to average out further!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.002(10.0%) |
Mkt cap ! $2.692M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $24.93K | 1.788M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 3838108 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 223248 | 4 |
View Market Depth
| Last trade - 13.23pm 18/07/2025 (20 minute delay) ? |
| OSX (ASX) Chart |